v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating activities    
Net income $ 1,363 $ 1,273
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:    
Depreciation and amortization 100 97
Noncash lease expense 40 31
Stock-based compensation 201 196
Deferred income tax expense (benefit) 76 102
Other investment gains (29)  
Net (gains) losses within CIPs 159 (104)
Net (purchases) proceeds within CIPs (393) (612)
(Earnings) losses from equity method investees (2) (25)
Distributions of earnings from equity method investees 25 8
Changes in operating assets and liabilities:    
Accounts receivable (27) (311)
Investments, trading 44 82
Other assets (3,234) (731)
Accrued compensation and benefits (1,852) (1,432)
Accounts payable and accrued liabilities 48 155
Other liabilities 3,059 698
Net cash provided by/(used in) operating activities (422) (573)
Investing activities    
Purchases of investments (140) (146)
Proceeds from sales and maturities of investments 73 110
Distributions of capital from equity method investees 19 34
Net consolidations (deconsolidations) of sponsored investment funds (3) (38)
Acquisitions, net of cash acquired   (1,062)
Purchases of property and equipment (147) (48)
Net cash provided by/(used in) investing activities (198) (1,150)
Financing activities    
Cash dividends paid (786) (661)
Repurchases of common stock (936) (568)
Net proceeds from (repayments of) borrowings by CIPs   13
Net contributions (redemptions/distributions) - noncontrolling interest holders 366 620
Other financing activities 5 5
Net cash provided by/(used in) financing activities (1,351) (591)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (90) (7)
Net increase/(decrease) in cash, cash equivalents and restricted cash (2,061) (2,321)
Cash, cash equivalents and restricted cash, beginning of period 9,340 8,681
Cash, cash equivalents and restricted cash, end of period 7,279 6,360
Supplemental schedule of noncash investing and financing transactions:    
Issuance of common stock 539 368
Increase (decrease) in noncontrolling interests due to net consolidation (deconsolidation) of sponsored investment funds $ (123) $ (607)